Primary drug resistance to the major anti-tuberculosis drugs in Japan. An investigation by the Tuberculosis Research Committee (Ryoken), Japan.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000636:Aminosalicylic Acids / Q000494:pharmacology; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid / Q000494:pharmacology; D007564:Japan; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011859:Radiography; D013223:Statistics as Topic; D013307:Streptomycin / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000382:microbiology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid; D013307:Streptomycin